GENE ONLINE|News &
Opinion
Blog

Johnson & Johnson
Trials & Approvals
#ESMO20: AZ, Merck’s PARP Inhibitor Surpasses Standard of Care in Prostate Cancer Trial
2020-09-22
M&A Johnson & Johnson
Johnson & Johnson to Acquire Momenta Pharmaceutical Inc. for $6.5 Billion
2020-08-20
COVID-19
BIO Digital 2020 Highlights: How COVID-19 Will Radically Change Biomedical R&D Across the Globe?
2020-06-21
Legend Biotech Closes Initial Public Offering Raising Big Money
2020-06-10
COVID-19 Vaccine
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
Technology Smart Device
Insider Perspectives on Digital Therapeutics
2019-10-17
Johnson & Johnson Deploys APAC Territory with New Headquarters in Singapore
2018-05-12
1 2 3
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top